Morphochem announces determination of the X-ray structure of Endothelin Converting Enzyme (ECE-1) complexed with Phosphoramidon
Morphochem applied its protein expression, purification, crystallization and structure determination capabilities to generate biostructural information for further optimization of inhibitor compounds against Endothelin-Converting Enzyme.
Commenting on the collaboration, Glenn E. Dale, Head of Biological Sciences at Morphochem said: "We are delighted that Morphochem could rapidly and successfully determine the three-dimensional structure of ECE-1 complexed with phosphoramidon, thereby providing the necessary tools to Solvay for this very important target."
Other news from the department science
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.